FEATURES
An interview with:
Dr.
Josef Smolen
June 2006 |
 |
Dr.
Josef Smolen talks about his highly cited work in the field
of rheumatoid arthritis. In our analysis of this field
over the past decade, Dr. Smolen’s work ranks at #7,
with 74 papers cited a total of 2,994 times. His
most-cited paper, "Infliximab and methotrexate in
the treatment of rheumatoid arthritis," (Lipsky
PE, et al., NEJM 343[22]: 1594-1602, 30
November 2000), ranks at #5 on our list of most-cited
rheumatoid arthritis over the past decade. Dr. Smolen
holds positions at both the Medical University of
Vienna and Hietzing Hospital in Vienna, Austria.
[read] |
|
An interview with:
Professor Paul Emery
May 2006 |
|
Professor
Paul Emery discusses his highly cited work on
rheumatoid arthritis. According to our analysis on the
subject, Professor Emery’s work ranks at #4, with
122 papers cited a total of 4,820 times. His
most-cited paper, "Infliximab and methotrexate in
the treatment of rheumatoid arthritis" (Lipsky
PE, et al., NEJM 343[22]:1594-1602, 30 November
2000) ranks at #5 on our list of the 20 most-cited
papers on rheumatoid arthritis in the past decade. In
Essential
Science Indicators ,
Professor Emery’s record includes 218 papers cited a
total of 6,209 times to date in the field of Clinical
Medicine.
[read] |
|
|
|
